If confirmed as health secretary, Robert F. Kennedy Jr. would oversee the Food and Drug Administration and other agencies ...

After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...

President Donald Trump’s nominee to run the Department of Health and Human Services, Robert F. Kennedy Jr., was in the hot ...

Merck said the Phase 3 "Hyperion" study, which was evaluating Winrevair versus placebo in recently diagnosed adults with PAH at intermediate or high risk of disease progression, had lost clinical ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look ...

(NYSE:MRK), a global healthcare leader, finds itself at a crossroads as it navigates challenges in its China Gardasil business while capitalizing on opportunities in pulmonary arterial hypertension ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

Ginkgo Bioworks faces ongoing revenue declines and high cash burn, despite cost-cutting efforts. Find out why I maintain a ...

You won't go to work for a drug company after you leave HHS, but you and I both know there's another way to make money,” Warren said.

Anova Enterprises, Inc. (Anova), a leading technology-enabled contract research organization (CRO) dedicated to accelerating clinical development, proudly announces the appointment of Fred Ma, MD, PhD ...

Senators challenged Kennedy, who was nominated as health secretary by President Trump, on his long track record of ...